Therefore, it is crucial to study the role of FXR and its signaling pathway in liver bile acid metabolism for exploring the pathogenesis of NAFLD and finding effective therapeutic targets. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.